Digital pill to help track alcohol recovery medication
Part of Mental health clinical trials.
This study tests a high-tech pill that tracks whether you're taking acamprosate, a medication that helps reduce alcohol cravings. You'll be in the trial if you have alcohol-related liver disease and are starting this medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Currently being treated for alcohol use disorder (AUD)
- Diagnosed with moderate to severe alcohol use disorder based on DSM-5 criteria
- Blood tests show signs of alcohol-related liver disease
- Planning to start acamprosate medication as part of your treatment
- No severe kidney problems (creatinine clearance must be above 30 mL/min)
- No allergies to acamprosate, magnesium, or silver
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a drug called apremilast can help people who drink heavily reduce their alcohol use. You will take the medication daily for several weeks and attend study visits to track your progress.
This Phase 2 study tests a brief medication approach meant to reduce “problem drinking.” It may help people cut back or stop alcohol use by adjusting brain signaling related to drinking cravings and urges.
This study tests a new way to quickly screen medications for alcohol use disorder (AUD). You will have lab sessions where your drinking is monitored to see how different medicines affect your alcohol use.
This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.
This study tests whether a pill called apremilast can help reduce drinking in people with alcohol use disorder. You'll take the medication and attend regular visits to see how it affects your alcohol cravings and use.
This trial tests whether a smartphone program can help people with alcohol-related liver disease reduce or stop drinking. If you have liver disease related to alcohol and have used alcohol in the past 6 months, this app-based support may be for you.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.